Women's perspectives on the management and consequences of hyperemesis gravidarum - a descriptive interview study

Objective: Hyperemesis gravidarum (HG) affects 0.3-3% of pregnant women and is a leading cause of hospitalization in early pregnancy. The aim of the study was to investigate women's treatment and management of HG, as well as the consequences of HG on women's daily life. Design and setting:...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scandinavian journal of primary health care 2019-03, Vol.37 (1), p.30-40
Hauptverfasser: Havnen, Gro C., Truong, Maria Bich-Thuy, Do, Mai-Linh H., Heitmann, Kristine, Holst, Lone, Nordeng, Hedvig
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 40
container_issue 1
container_start_page 30
container_title Scandinavian journal of primary health care
container_volume 37
creator Havnen, Gro C.
Truong, Maria Bich-Thuy
Do, Mai-Linh H.
Heitmann, Kristine
Holst, Lone
Nordeng, Hedvig
description Objective: Hyperemesis gravidarum (HG) affects 0.3-3% of pregnant women and is a leading cause of hospitalization in early pregnancy. The aim of the study was to investigate women's treatment and management of HG, as well as the consequences of HG on women's daily life. Design and setting: A cross-sectional study based on a structured telephone interview and an online questionnaire. Participants were recruited by social media and by the Norwegian patient's organization for HG. Subjects: Norwegian women that experienced HG. Main outcome measure: Women's perspectives on management and consequences of HG. Results: The study included 107 women. Maternal morbidity was profound; about 3/4 of participants were hospitalized due to HG, and the majority showed clinical signs of dehydration (79%), ketonuria (75%), and >5% weight loss (84%). Antiemetics were used by >90% and frequently prescribed "as needed". Metoclopramide (71%) and meclozine (51%) were most commonly used. Participants described HG as having severe psychosocial consequences and profound impact on daily activities. Almost two out of five reported thoughts of elective abortion, and 8 women had at least one elective pregnancy termination due to HG. Overall, 20 women (19%) changed GPs due to dissatisfaction with HG management. Conclusion: Despite the high psychosocial burden and major impact on daily activities, many women with HG reported a lack of support from healthcare professionals and suboptimal management. Greater awareness and knowledge among healthcare professionals is needed to improve care for women with HG. Key Points There is a paucity of studies on management and the consequences of HG on women's daily lives and psychosocial burden. We found that: * Many women described HG as one of their worst life experiences with profound morbidity. * Many women reported suboptimal management of HG and lack of support from healthcare professionals. * Greater understanding of patient perspectives among healthcare professionals is important to improve care and management for HG patients.
doi_str_mv 10.1080/02813432.2019.1569424
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6454401</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_fa7dcd71fbdd4f1d83db9ab71e0817b3</doaj_id><sourcerecordid>2276054122</sourcerecordid><originalsourceid>FETCH-LOGICAL-c586t-58cc8ae17d9ece10a6d475eb6f9c87a1ef20fda494f766f47c38acc206f4c8373</originalsourceid><addsrcrecordid>eNp9kkuP0zAUhSMEYsrATwAssYBNil-JnQ0CjXiMNBIbEEvrxo_WVWJ37LSj_nsc2o4YFqxs-Z77Xfv4VNVLgpcES_weU0kYZ3RJMemWpGk7TvmjakEaTGshKH9cLWZNPYsuqmc5bzAmEnfsaXXBsKSUNnxR3f6Kow1vM9ralLdWT35vM4oBTWuLRgiwsqU-IQgG6Riyvd3ZoGeJQ-tDaSrl7DNaJdh7A2k3ohoBMjbr5LczDfkw2bT39g7laWcOz6snDoZsX5zWy-rnl88_rr7VN9-_Xl99uql1I9upbqTWEiwRprPaEgyt4aKxfes6LQUQ6yh2BnjHnWhbx4VmErSmuOy1ZIJdVtdHromwUdvkR0gHFcGrPwcxrRSkyevBKgfCaCOI643hjhjJTN9BL4jFkoieFdaHI2u760drdHEkwfAA-rAS_Fqt4l61vOEckwJ4fQQUV_LkgwoxgSof2VAlGGtlUbw7jUixeJwnNfqs7TBAsHGXFSVSNJS1Yoa9-Ue6ibsUipmKUtHihhNKi6o5j4w5J-vur0vwPBmrc4TUHCF1ilDpe_X3W--7zpkpgo9HgQ8uphHuYhqMmuAwxOQSBO2zYv-f8Rs0uteN</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2276054122</pqid></control><display><type>article</type><title>Women's perspectives on the management and consequences of hyperemesis gravidarum - a descriptive interview study</title><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>Taylor &amp; Francis Open Access</source><source>MEDLINE</source><source>NORA - Norwegian Open Research Archives</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Havnen, Gro C. ; Truong, Maria Bich-Thuy ; Do, Mai-Linh H. ; Heitmann, Kristine ; Holst, Lone ; Nordeng, Hedvig</creator><creatorcontrib>Havnen, Gro C. ; Truong, Maria Bich-Thuy ; Do, Mai-Linh H. ; Heitmann, Kristine ; Holst, Lone ; Nordeng, Hedvig</creatorcontrib><description>Objective: Hyperemesis gravidarum (HG) affects 0.3-3% of pregnant women and is a leading cause of hospitalization in early pregnancy. The aim of the study was to investigate women's treatment and management of HG, as well as the consequences of HG on women's daily life. Design and setting: A cross-sectional study based on a structured telephone interview and an online questionnaire. Participants were recruited by social media and by the Norwegian patient's organization for HG. Subjects: Norwegian women that experienced HG. Main outcome measure: Women's perspectives on management and consequences of HG. Results: The study included 107 women. Maternal morbidity was profound; about 3/4 of participants were hospitalized due to HG, and the majority showed clinical signs of dehydration (79%), ketonuria (75%), and &gt;5% weight loss (84%). Antiemetics were used by &gt;90% and frequently prescribed "as needed". Metoclopramide (71%) and meclozine (51%) were most commonly used. Participants described HG as having severe psychosocial consequences and profound impact on daily activities. Almost two out of five reported thoughts of elective abortion, and 8 women had at least one elective pregnancy termination due to HG. Overall, 20 women (19%) changed GPs due to dissatisfaction with HG management. Conclusion: Despite the high psychosocial burden and major impact on daily activities, many women with HG reported a lack of support from healthcare professionals and suboptimal management. Greater awareness and knowledge among healthcare professionals is needed to improve care for women with HG. Key Points There is a paucity of studies on management and the consequences of HG on women's daily lives and psychosocial burden. We found that: * Many women described HG as one of their worst life experiences with profound morbidity. * Many women reported suboptimal management of HG and lack of support from healthcare professionals. * Greater understanding of patient perspectives among healthcare professionals is important to improve care and management for HG patients.</description><identifier>ISSN: 0281-3432</identifier><identifier>ISSN: 1502-7724</identifier><identifier>EISSN: 1502-7724</identifier><identifier>DOI: 10.1080/02813432.2019.1569424</identifier><identifier>PMID: 30822254</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>Abortion ; Abortion, Induced ; Activities of Daily Living ; Adult ; Antiemetics - therapeutic use ; Attitude ; Cross-Sectional Studies ; Dehydration ; Dehydration - complications ; Dehydration - epidemiology ; Emotions ; Female ; Health care ; HG management ; Hospitalization ; Humans ; Hyperemesis gravidarum ; Hyperemesis gravidarum (HG) ; Hyperemesis Gravidarum - complications ; Hyperemesis Gravidarum - psychology ; Hyperemesis Gravidarum - therapy ; Interviews ; Ketosis - complications ; Ketosis - epidemiology ; Life experiences ; Meclizine - therapeutic use ; Medical personnel ; Metoclopramide - therapeutic use ; Morbidity ; Nausea ; Nausea - complications ; Nausea - psychology ; Nausea - therapy ; Nausea and vomiting in pregnancy (NVP) ; Norway - epidemiology ; Original ; patient perspectives ; Patient Satisfaction ; Pregnancy ; Pregnancy complications ; Pregnant Women - psychology ; Psychosocial factors ; Quality of Life ; Severity of Illness Index ; Social media ; Surveys and Questionnaires ; Termination ; Vomiting ; Weight Loss ; Womens health</subject><ispartof>Scandinavian journal of primary health care, 2019-03, Vol.37 (1), p.30-40</ispartof><rights>2019 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group. 2019</rights><rights>2019 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>info:eu-repo/semantics/openAccess</rights><rights>2019 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group. 2019 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c586t-58cc8ae17d9ece10a6d475eb6f9c87a1ef20fda494f766f47c38acc206f4c8373</citedby><cites>FETCH-LOGICAL-c586t-58cc8ae17d9ece10a6d475eb6f9c87a1ef20fda494f766f47c38acc206f4c8373</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454401/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454401/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,12825,26544,27479,27901,27902,30976,53766,53768,59116,59117</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30822254$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Havnen, Gro C.</creatorcontrib><creatorcontrib>Truong, Maria Bich-Thuy</creatorcontrib><creatorcontrib>Do, Mai-Linh H.</creatorcontrib><creatorcontrib>Heitmann, Kristine</creatorcontrib><creatorcontrib>Holst, Lone</creatorcontrib><creatorcontrib>Nordeng, Hedvig</creatorcontrib><title>Women's perspectives on the management and consequences of hyperemesis gravidarum - a descriptive interview study</title><title>Scandinavian journal of primary health care</title><addtitle>Scand J Prim Health Care</addtitle><description>Objective: Hyperemesis gravidarum (HG) affects 0.3-3% of pregnant women and is a leading cause of hospitalization in early pregnancy. The aim of the study was to investigate women's treatment and management of HG, as well as the consequences of HG on women's daily life. Design and setting: A cross-sectional study based on a structured telephone interview and an online questionnaire. Participants were recruited by social media and by the Norwegian patient's organization for HG. Subjects: Norwegian women that experienced HG. Main outcome measure: Women's perspectives on management and consequences of HG. Results: The study included 107 women. Maternal morbidity was profound; about 3/4 of participants were hospitalized due to HG, and the majority showed clinical signs of dehydration (79%), ketonuria (75%), and &gt;5% weight loss (84%). Antiemetics were used by &gt;90% and frequently prescribed "as needed". Metoclopramide (71%) and meclozine (51%) were most commonly used. Participants described HG as having severe psychosocial consequences and profound impact on daily activities. Almost two out of five reported thoughts of elective abortion, and 8 women had at least one elective pregnancy termination due to HG. Overall, 20 women (19%) changed GPs due to dissatisfaction with HG management. Conclusion: Despite the high psychosocial burden and major impact on daily activities, many women with HG reported a lack of support from healthcare professionals and suboptimal management. Greater awareness and knowledge among healthcare professionals is needed to improve care for women with HG. Key Points There is a paucity of studies on management and the consequences of HG on women's daily lives and psychosocial burden. We found that: * Many women described HG as one of their worst life experiences with profound morbidity. * Many women reported suboptimal management of HG and lack of support from healthcare professionals. * Greater understanding of patient perspectives among healthcare professionals is important to improve care and management for HG patients.</description><subject>Abortion</subject><subject>Abortion, Induced</subject><subject>Activities of Daily Living</subject><subject>Adult</subject><subject>Antiemetics - therapeutic use</subject><subject>Attitude</subject><subject>Cross-Sectional Studies</subject><subject>Dehydration</subject><subject>Dehydration - complications</subject><subject>Dehydration - epidemiology</subject><subject>Emotions</subject><subject>Female</subject><subject>Health care</subject><subject>HG management</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Hyperemesis gravidarum</subject><subject>Hyperemesis gravidarum (HG)</subject><subject>Hyperemesis Gravidarum - complications</subject><subject>Hyperemesis Gravidarum - psychology</subject><subject>Hyperemesis Gravidarum - therapy</subject><subject>Interviews</subject><subject>Ketosis - complications</subject><subject>Ketosis - epidemiology</subject><subject>Life experiences</subject><subject>Meclizine - therapeutic use</subject><subject>Medical personnel</subject><subject>Metoclopramide - therapeutic use</subject><subject>Morbidity</subject><subject>Nausea</subject><subject>Nausea - complications</subject><subject>Nausea - psychology</subject><subject>Nausea - therapy</subject><subject>Nausea and vomiting in pregnancy (NVP)</subject><subject>Norway - epidemiology</subject><subject>Original</subject><subject>patient perspectives</subject><subject>Patient Satisfaction</subject><subject>Pregnancy</subject><subject>Pregnancy complications</subject><subject>Pregnant Women - psychology</subject><subject>Psychosocial factors</subject><subject>Quality of Life</subject><subject>Severity of Illness Index</subject><subject>Social media</subject><subject>Surveys and Questionnaires</subject><subject>Termination</subject><subject>Vomiting</subject><subject>Weight Loss</subject><subject>Womens health</subject><issn>0281-3432</issn><issn>1502-7724</issn><issn>1502-7724</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>BENPR</sourceid><sourceid>3HK</sourceid><sourceid>DOA</sourceid><recordid>eNp9kkuP0zAUhSMEYsrATwAssYBNil-JnQ0CjXiMNBIbEEvrxo_WVWJ37LSj_nsc2o4YFqxs-Z77Xfv4VNVLgpcES_weU0kYZ3RJMemWpGk7TvmjakEaTGshKH9cLWZNPYsuqmc5bzAmEnfsaXXBsKSUNnxR3f6Kow1vM9ralLdWT35vM4oBTWuLRgiwsqU-IQgG6Riyvd3ZoGeJQ-tDaSrl7DNaJdh7A2k3ohoBMjbr5LczDfkw2bT39g7laWcOz6snDoZsX5zWy-rnl88_rr7VN9-_Xl99uql1I9upbqTWEiwRprPaEgyt4aKxfes6LQUQ6yh2BnjHnWhbx4VmErSmuOy1ZIJdVtdHromwUdvkR0gHFcGrPwcxrRSkyevBKgfCaCOI643hjhjJTN9BL4jFkoieFdaHI2u760drdHEkwfAA-rAS_Fqt4l61vOEckwJ4fQQUV_LkgwoxgSof2VAlGGtlUbw7jUixeJwnNfqs7TBAsHGXFSVSNJS1Yoa9-Ue6ibsUipmKUtHihhNKi6o5j4w5J-vur0vwPBmrc4TUHCF1ilDpe_X3W--7zpkpgo9HgQ8uphHuYhqMmuAwxOQSBO2zYv-f8Rs0uteN</recordid><startdate>20190301</startdate><enddate>20190301</enddate><creator>Havnen, Gro C.</creator><creator>Truong, Maria Bich-Thuy</creator><creator>Do, Mai-Linh H.</creator><creator>Heitmann, Kristine</creator><creator>Holst, Lone</creator><creator>Nordeng, Hedvig</creator><general>Taylor &amp; Francis</general><general>Taylor &amp; Francis LLC</general><general>Taylor &amp; Francis Group</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QJ</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>7X8</scope><scope>3HK</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20190301</creationdate><title>Women's perspectives on the management and consequences of hyperemesis gravidarum - a descriptive interview study</title><author>Havnen, Gro C. ; Truong, Maria Bich-Thuy ; Do, Mai-Linh H. ; Heitmann, Kristine ; Holst, Lone ; Nordeng, Hedvig</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c586t-58cc8ae17d9ece10a6d475eb6f9c87a1ef20fda494f766f47c38acc206f4c8373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Abortion</topic><topic>Abortion, Induced</topic><topic>Activities of Daily Living</topic><topic>Adult</topic><topic>Antiemetics - therapeutic use</topic><topic>Attitude</topic><topic>Cross-Sectional Studies</topic><topic>Dehydration</topic><topic>Dehydration - complications</topic><topic>Dehydration - epidemiology</topic><topic>Emotions</topic><topic>Female</topic><topic>Health care</topic><topic>HG management</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Hyperemesis gravidarum</topic><topic>Hyperemesis gravidarum (HG)</topic><topic>Hyperemesis Gravidarum - complications</topic><topic>Hyperemesis Gravidarum - psychology</topic><topic>Hyperemesis Gravidarum - therapy</topic><topic>Interviews</topic><topic>Ketosis - complications</topic><topic>Ketosis - epidemiology</topic><topic>Life experiences</topic><topic>Meclizine - therapeutic use</topic><topic>Medical personnel</topic><topic>Metoclopramide - therapeutic use</topic><topic>Morbidity</topic><topic>Nausea</topic><topic>Nausea - complications</topic><topic>Nausea - psychology</topic><topic>Nausea - therapy</topic><topic>Nausea and vomiting in pregnancy (NVP)</topic><topic>Norway - epidemiology</topic><topic>Original</topic><topic>patient perspectives</topic><topic>Patient Satisfaction</topic><topic>Pregnancy</topic><topic>Pregnancy complications</topic><topic>Pregnant Women - psychology</topic><topic>Psychosocial factors</topic><topic>Quality of Life</topic><topic>Severity of Illness Index</topic><topic>Social media</topic><topic>Surveys and Questionnaires</topic><topic>Termination</topic><topic>Vomiting</topic><topic>Weight Loss</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Havnen, Gro C.</creatorcontrib><creatorcontrib>Truong, Maria Bich-Thuy</creatorcontrib><creatorcontrib>Do, Mai-Linh H.</creatorcontrib><creatorcontrib>Heitmann, Kristine</creatorcontrib><creatorcontrib>Holst, Lone</creatorcontrib><creatorcontrib>Nordeng, Hedvig</creatorcontrib><collection>Taylor &amp; Francis Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><collection>NORA - Norwegian Open Research Archives</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Scandinavian journal of primary health care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Havnen, Gro C.</au><au>Truong, Maria Bich-Thuy</au><au>Do, Mai-Linh H.</au><au>Heitmann, Kristine</au><au>Holst, Lone</au><au>Nordeng, Hedvig</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Women's perspectives on the management and consequences of hyperemesis gravidarum - a descriptive interview study</atitle><jtitle>Scandinavian journal of primary health care</jtitle><addtitle>Scand J Prim Health Care</addtitle><date>2019-03-01</date><risdate>2019</risdate><volume>37</volume><issue>1</issue><spage>30</spage><epage>40</epage><pages>30-40</pages><issn>0281-3432</issn><issn>1502-7724</issn><eissn>1502-7724</eissn><abstract>Objective: Hyperemesis gravidarum (HG) affects 0.3-3% of pregnant women and is a leading cause of hospitalization in early pregnancy. The aim of the study was to investigate women's treatment and management of HG, as well as the consequences of HG on women's daily life. Design and setting: A cross-sectional study based on a structured telephone interview and an online questionnaire. Participants were recruited by social media and by the Norwegian patient's organization for HG. Subjects: Norwegian women that experienced HG. Main outcome measure: Women's perspectives on management and consequences of HG. Results: The study included 107 women. Maternal morbidity was profound; about 3/4 of participants were hospitalized due to HG, and the majority showed clinical signs of dehydration (79%), ketonuria (75%), and &gt;5% weight loss (84%). Antiemetics were used by &gt;90% and frequently prescribed "as needed". Metoclopramide (71%) and meclozine (51%) were most commonly used. Participants described HG as having severe psychosocial consequences and profound impact on daily activities. Almost two out of five reported thoughts of elective abortion, and 8 women had at least one elective pregnancy termination due to HG. Overall, 20 women (19%) changed GPs due to dissatisfaction with HG management. Conclusion: Despite the high psychosocial burden and major impact on daily activities, many women with HG reported a lack of support from healthcare professionals and suboptimal management. Greater awareness and knowledge among healthcare professionals is needed to improve care for women with HG. Key Points There is a paucity of studies on management and the consequences of HG on women's daily lives and psychosocial burden. We found that: * Many women described HG as one of their worst life experiences with profound morbidity. * Many women reported suboptimal management of HG and lack of support from healthcare professionals. * Greater understanding of patient perspectives among healthcare professionals is important to improve care and management for HG patients.</abstract><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>30822254</pmid><doi>10.1080/02813432.2019.1569424</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0281-3432
ispartof Scandinavian journal of primary health care, 2019-03, Vol.37 (1), p.30-40
issn 0281-3432
1502-7724
1502-7724
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6454401
source Applied Social Sciences Index & Abstracts (ASSIA); Taylor & Francis Open Access; MEDLINE; NORA - Norwegian Open Research Archives; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Abortion
Abortion, Induced
Activities of Daily Living
Adult
Antiemetics - therapeutic use
Attitude
Cross-Sectional Studies
Dehydration
Dehydration - complications
Dehydration - epidemiology
Emotions
Female
Health care
HG management
Hospitalization
Humans
Hyperemesis gravidarum
Hyperemesis gravidarum (HG)
Hyperemesis Gravidarum - complications
Hyperemesis Gravidarum - psychology
Hyperemesis Gravidarum - therapy
Interviews
Ketosis - complications
Ketosis - epidemiology
Life experiences
Meclizine - therapeutic use
Medical personnel
Metoclopramide - therapeutic use
Morbidity
Nausea
Nausea - complications
Nausea - psychology
Nausea - therapy
Nausea and vomiting in pregnancy (NVP)
Norway - epidemiology
Original
patient perspectives
Patient Satisfaction
Pregnancy
Pregnancy complications
Pregnant Women - psychology
Psychosocial factors
Quality of Life
Severity of Illness Index
Social media
Surveys and Questionnaires
Termination
Vomiting
Weight Loss
Womens health
title Women's perspectives on the management and consequences of hyperemesis gravidarum - a descriptive interview study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T06%3A10%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Women's%20perspectives%20on%20the%20management%20and%20consequences%20of%20hyperemesis%20gravidarum%20-%20a%20descriptive%20interview%20study&rft.jtitle=Scandinavian%20journal%20of%20primary%20health%20care&rft.au=Havnen,%20Gro%20C.&rft.date=2019-03-01&rft.volume=37&rft.issue=1&rft.spage=30&rft.epage=40&rft.pages=30-40&rft.issn=0281-3432&rft.eissn=1502-7724&rft_id=info:doi/10.1080/02813432.2019.1569424&rft_dat=%3Cproquest_pubme%3E2276054122%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2276054122&rft_id=info:pmid/30822254&rft_doaj_id=oai_doaj_org_article_fa7dcd71fbdd4f1d83db9ab71e0817b3&rfr_iscdi=true